Tags

Type your tag names separated by a space and hit enter

Cardiovascular diseases among patients with schizophrenia.
Asian J Psychiatr 2016; 19:28-36AJ

Abstract

The presence of comorbid physical illnesses especially, cardiovascular diseases (CVD) in schizophrenia is a growing area of concern in recent years. In order to reduce disease burden, to improve quality of life and to provide holistic care, it is important to know about the relationship between schizophrenia and CVD. The objective of this review is to explore the extent of CVD problems, relevant risk factors and potential measures for early diagnosis and prevention of CVD among patients with schizophrenia. Worldwide studies show that patients with schizophrenia have a higher mortality and lower life expectancy than the general population. CVD is the leading cause of increased mortality in schizophrenia. Common CVD risk factors in schizophrenia include metabolic syndrome, sedentary behaviour, tobacco smoking, effects of antipsychotics, long chain omega-3 fatty acid deficiency and shared genetics between CVD and schizophrenia. The potential methods for early detection and prevention of CVD in schizophrenia are also discussed. Though the patients with schizophrenia form a high risk group for CVD, consensus guidelines for early detection and prevention of CVD in schizophrenia are lacking. Comorbidity of CVD in schizophrenia needs more serious attention by clinicians and researchers.

Authors+Show Affiliations

Department of Community and Family Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.Department of Community and Family Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.Department of Public Health, General Directorate of Health Affairs in Tabuk Region, Tabuk, Saudi Arabia.Department of Community and Family Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.Department of Community and Family Medicine, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.Department of Medicine Based Disciplines, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Sabah, Malaysia.Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada; Department of Family Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: turin.chowdhury@ucalgary.ca.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

26957335

Citation

Azad, Muhammad Chanchal, et al. "Cardiovascular Diseases Among Patients With Schizophrenia." Asian Journal of Psychiatry, vol. 19, 2016, pp. 28-36.
Azad MC, Shoesmith WD, Al Mamun M, et al. Cardiovascular diseases among patients with schizophrenia. Asian J Psychiatr. 2016;19:28-36.
Azad, M. C., Shoesmith, W. D., Al Mamun, M., Abdullah, A. F., Naing, D. K., Phanindranath, M., & Turin, T. C. (2016). Cardiovascular diseases among patients with schizophrenia. Asian Journal of Psychiatry, 19, pp. 28-36. doi:10.1016/j.ajp.2015.11.012.
Azad MC, et al. Cardiovascular Diseases Among Patients With Schizophrenia. Asian J Psychiatr. 2016;19:28-36. PubMed PMID: 26957335.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cardiovascular diseases among patients with schizophrenia. AU - Azad,Muhammad Chanchal, AU - Shoesmith,Wendy Diana, AU - Al Mamun,Mohammad, AU - Abdullah,Ahmad Faris, AU - Naing,Daw Khin Saw, AU - Phanindranath,Mahadasa, AU - Turin,Tanvir Chowdhury, Y1 - 2015/12/14/ PY - 2015/06/29/received PY - 2015/11/01/revised PY - 2015/11/29/accepted PY - 2016/3/10/entrez PY - 2016/3/10/pubmed PY - 2016/12/20/medline KW - Cardiovascular diseases KW - Early detection KW - Prevention KW - Risk factors KW - Schizophrenia SP - 28 EP - 36 JF - Asian journal of psychiatry JO - Asian J Psychiatr VL - 19 N2 - The presence of comorbid physical illnesses especially, cardiovascular diseases (CVD) in schizophrenia is a growing area of concern in recent years. In order to reduce disease burden, to improve quality of life and to provide holistic care, it is important to know about the relationship between schizophrenia and CVD. The objective of this review is to explore the extent of CVD problems, relevant risk factors and potential measures for early diagnosis and prevention of CVD among patients with schizophrenia. Worldwide studies show that patients with schizophrenia have a higher mortality and lower life expectancy than the general population. CVD is the leading cause of increased mortality in schizophrenia. Common CVD risk factors in schizophrenia include metabolic syndrome, sedentary behaviour, tobacco smoking, effects of antipsychotics, long chain omega-3 fatty acid deficiency and shared genetics between CVD and schizophrenia. The potential methods for early detection and prevention of CVD in schizophrenia are also discussed. Though the patients with schizophrenia form a high risk group for CVD, consensus guidelines for early detection and prevention of CVD in schizophrenia are lacking. Comorbidity of CVD in schizophrenia needs more serious attention by clinicians and researchers. SN - 1876-2026 UR - https://www.unboundmedicine.com/medline/citation/26957335/full_citation L2 - https://linkinghub.elsevier.com/retrieve/pii/S1876-2018(15)00284-1 DB - PRIME DP - Unbound Medicine ER -